RxAll
RxAll is a Nigeria-based healthtech company operating a digital pharmaceutical infrastructure platform centered on its AI-powered RxScanner device for drug authentication, serving regulators, wholesalers, pharmacies, and hospitals across Africa and Southeast Asia.
- Company typePrivate
- Founded2019
- HeadquartersNew Haven, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What RxAll does
RxAll is a Nigeria-headquartered healthtech company that operates a digital infrastructure platform for pharmaceutical supply chain integrity, primarily serving African and Southeast Asian markets. Its core product is the RxScanner, a handheld AI/ML-powered IoT device that uses spectral chemometric modeling and computer vision to authenticate drug quality through packaging in 20 seconds, achieving 99.9% accuracy across 400+ drugs in its spectral library. The technology originated from 8+ years of research at Yale University and holds ISO and CE certifications. All RxScanner-authenticated results are stored on blockchain for supply chain traceability.
Beyond the hardware device, RxAll operates an integrated platform including RxDelivered (a marketplace of 200+ licensed pharmacies selling verified authentic medicines), RxPay (B2B inventory financing for pharmacies and wholesalers), RxPOS (pharmacy management software), Rx-APIs (digitization APIs for inventory, insurance claims, and invoice financing), RxAcademy (pharmacist training with up to $10K in financing per person), RxHMO (insurance integration), and RxGO (curated pharmacy network). The company targets government regulators (notably NAFDAC in Nigeria, authenticating 100K+ drugs monthly), wholesalers, pharmacies, hospitals, and individual buyers. Revenue is generated through hardware unit sales, marketplace commissions, financing fees, software subscriptions, and API licensing. The company has raised approximately $6.78M across multiple rounds from investors including SOSV, Launch Africa Ventures, Loftyinc, Plug and Play, Katapult, and Savannah Fund, and operates with 11–50 employees.
RxAll firmographics
Firmographics- Name
- RxAll
- Legal name
- RxAll
- Website
- https://rxall.net
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- RxAll is a Nigeria-based healthtech company operating a digital pharmaceutical infrastructure platform centered on its AI-powered RxScanner device for drug authentication, serving regulators, wholesalers, pharmacies, and hospitals across Africa and Southeast Asia.
- Ownership category
- akta.pro rank
RxAll industry classification
Industry- Product category
- Pharmaceutical Authentication Technology
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), In-Vitro Diagnostic Substance Manufacturing (325413), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Pharmacovigilance & Drug Safety Software (HLAGAJAK)
- akta.pro secondary industries
- Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
Keywords
Where RxAll is headquartered
LocationHeadquarters
- HQ city
- New Haven
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
RxAll business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- RxScanner Device Sales: Sale of the RxScanner handheld IoT device, which uses AI and machine learning to authenticate drug quality. The device is sold to FDAs, hospitals, pharmacies, wholesalers, and NGOs for on-site drug quality testing. Pricing is quoted per unit with bulk inquiries supported.
- RxDelivered Marketplace Commission: RxDelivered connects buyers with verified sellers of authentic medicines. The platform likely earns commissions on transactions facilitated between buyers and sellers through the authenticated marketplace. 200+ licensed marketplaces are listed.
- RxPay Financing Services: RxPay enables pharmacies and wholesalers to get funding on soft terms for required purchases, preventing stock-outs. Revenue may come from financing fees charged on loans extended to pharmacies and wholesalers. RxAcademy also provides up to $10K inventory and asset financing per person.
- Rx-APIs Licensing: RxAll offers inventory, insurance claims, and invoice financing APIs to third parties, generating licensing or usage-based revenue from pharmacies, HMOs, and healthcare systems that integrate RxAll's digital infrastructure.
- RxPOS Software: Sales and purchases software for pharmacies providing automated inventory management, reordering, and transaction processing. Likely generates subscription or per-seat revenue from pharmacy customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | RxScanner hardware units sold to regulators, pharma companies, hospitals, and NGOs |
| Other | Multi-year contract | RxAcademy training platform with up to $10K financing |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
RxAll product offering
Product offeringCore offering
RxAll provides a digital infrastructure platform for healthcare centered on the RxScanner, a handheld AI-powered IoT device that authenticates drug quality in 20 seconds with 99.9% accuracy. Surrounding the device is an ecosystem comprising the RxDelivered marketplace for verified medicines, RxPay B2B financing, RxPOS pharmacy management software, and Rx-APIs for third-party integration. The platform is designed to combat counterfeit drugs and enable pharmacies, hospitals, wholesalers, and government regulators to verify, source, finance, and manage medicines.
Product overview
RxAll is a digital infrastructure platform for healthcare that provides a comprehensive ecosystem of products and services. The platform centers on RxScanner, an AI-powered drug authentication device that identifies drug quality through packaging using computer vision. RxScanner-verified products are then made available through RxDelivered, a trusted marketplace connecting buyers and sellers. The ecosystem is augmented by financial services (RxPay for B2B funding), point-of-sale software (RxPOS), pharmacy training (RxAcademy with up to $10K financing), insurance integration (RxHMO), and a curated pharmacy network (RxGO). The company also offers Rx-APIs for pharmacy digitization. The platform targets pharmacies, hospitals, wholesalers, government regulators, insurance companies, and lenders across the drug supply chain.
Differentiator
Problem solved
Functional benefit
Brands
- RxScanner: Award-winning healthcare IoT platform that uses AI and machine learning to check and confirm drug quality. Portable device that provides real-time results via iOS and Android app with 99% accuracy, ISO and CE certified.
- RxDelivered
- RxPay
- Rx-APIs
- RxPOS
- RxAcademy
- RxHMO
- RxGO
Products and services
- RxScanner Handheld AI and machine learning IoT device that identifies drug samples and quality levels through packaging in 20 seconds with 99.9% accuracy, returning results to a mobile app. Built on 8+ years of Yale University research, ISO and CE certified, and used by regulators, hospitals, pharmacies, wholesalers, and NGOs.
- RxDelivered Trusted online marketplace connecting buyers with proven sellers of RxScanner-verified authentic medicines at affordable prices, serving pharmacies, hospitals, and individual buyers across 200+ licensed marketplaces.
- RxPay B2B financing platform that provides funding on soft terms to pharmacies and wholesalers to prevent stock-outs and keep authentic drugs accessible without driving prices up. RxAcademy program offers up to $10K-$20K in inventory and asset financing per pharmacist.
- RxPOS Sales and purchases software for pharmacies that automates transactions, enables quick payments and invoicing, manages inventory and reordering, and sends notifications when medications run out of stock or expire.
- Rx-APIs Developer APIs that digitize pharmacy operations through inventory management, insurance claims processing, and invoice financing, enabling third-party healthcare systems, pharmacies, HMOs, and hospitals to integrate with RxAll's digital infrastructure.
- RxAcademy On-demand training platform that teaches pharmacists how to open and run a pharmacy business, with access to up to $10K-$20K in inventory and asset financing per person for graduates.
- RxHMO Health Maintenance Organization service that provides insured customers with access to authentic drugs from accredited pharmacies on RxDelivered, credits HMOs, and enables customers to get prescriptions faster.
- RxGO Curated pharmacy network offering authenticated quality drugs and consumer products available for in-person and online ordering with delivery, accessible via the RxDelivered platform.
Quantifiable outcome
- 100K+ drugs authenticated monthly across Nigeria with NAFDAC
- +6 more outcomes
Companies that use RxAll
Customer profileNamed customers4 records
Segments7 records
Ideal customer profiles6 records
RxAll technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
RxAll partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered flagship and core.
- NAFDAC (National Agency for Food and Drug Administration and Control)flagshipNAFDAC, Nigeria's drug regulatory body, partnered with RxAll to deploy RxScanner across post-marketing surveillance inspectors nationwide. Results: 100K+ drugs authenticated monthly across Nigeria, 400+ drugs in spectral library. This is RxAll's flagship government partnership demonstrating large-scale deployment.
- Ibadan Drug Fulfillment Center (IDFC)coreIDFC used RxScanner to authenticate drug quality before supplying to 4K+ customers across Nigeria. Results: 500K+ patients accessed safe drugs, 50% sales growth, 150K+ drugs tested. IDFC serves as a key case study demonstrating RxAll's impact on the distribution chain.
- E-Health Africa Clinics (EHA)coreE-Health Africa Clinics deployed RxScanner to detect fake anti-malarial drugs in Northern Nigeria. The partnership demonstrates RxAll's application in clinical settings with results: 30K+ antimalarials tested in 1 year.
- NAFDAC / Nigeria FDAflagshipNAFDAC uses RxScanner to screen the quality of imported drugs at ports and during post-marketing surveillance. This government partnership provides wide-scale deployment of RxAll's technology across Nigeria's drug quality monitoring infrastructure.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
RxAll competitors and assessment
Company assessmentDirect peers
- Sproxil: Sproxil is a Nigeria-headquartered pharma anti-counterfeiting company using mobile verification (SMS/app-based codes) to authenticate drugs, directly competing with RxAll's RxScanner in the same African markets and customer base.
- mPedigree (now RxAfrika): mPedigree is a Ghana-based drug authentication platform using mobile verification codes, serving the same pharmaceutical supply chain integrity use case as RxAll in West and East African markets.
- PharmaSecure: PharmaSecure provides SMS-based authentication and serialization for pharmaceuticals in emerging markets (notably India and Africa), directly comparable to RxAll's anti-counterfeit drug authentication offering.
- RxERP (mPedigree Group): RxERP provides pharmacy management and ERP software to African pharmacies, overlapping with RxAll's RxPOS offering for the same pharmacist customer base and pharmacy digitization use case.
Broad incumbents
- Systech (Dover): Systech provides pharmaceutical serialization, traceability, and authentication solutions as part of Dover's broader industrial portfolio, offering overlapping drug authentication capabilities to global pharma manufacturers.
- Optel Group: Optel is a global pharma supply chain traceability and serialization company serving large pharma manufacturers with end-to-end track-and-trace platforms that compete with RxAll at the manufacturing/distribution tier.
- SAP (Advanced Track and Trace): SAP's ATTP and pharmaceutical supply chain solutions serve large global pharma manufacturers with serialization and traceability, representing an enterprise incumbent whose adoption by multinational pharma could limit RxAll's addressable market.
Emerging players
- TruTag Technologies: TruTag develops ingestible spectral tag authentication for pharmaceuticals and other products, representing an alternative technology approach (tag-based vs RxScanner's hyperspectral scanning) to drug authentication.
- Zipline: Zipline is a drone-based medical supply delivery company serving African hospitals and pharmacies, with overlapping customer base (hospitals, regulators, pharmacies) and adjacent supply chain integrity mission to RxAll's drug authentication work.
Regional players
- Selcom / Tola Mobile: Tola Mobile provides fintech and inventory financing infrastructure for African SMEs including pharmacies, comparable to RxAll's RxPay B2B financing and Rx-APIs integration offerings across East Africa.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
RxAll social profiles
Digital presenceRxAll compliance and trust
Trust signalCompliance2 records
RxAll financial estimates
Financial estimateRevenue estimate
Valuation estimate
RxAll leadership team
Management profileNumber of profiles
Profiles9 records
RxAll funding detail
Funding detailFunding overview
Funding rounds8 records
Investors19 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RxAll M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RxAll
What does RxAll do?
RxAll provides a digital infrastructure platform for healthcare centered on the RxScanner, a handheld AI-powered IoT device that authenticates drug quality in 20 seconds with 99.9% accuracy. Surrounding the device is an ecosystem comprising the RxDelivered marketplace for verified medicines, RxPay B2B financing, RxPOS pharmacy management software, and Rx-APIs for third-party integration. The platform is designed to combat counterfeit drugs and enable pharmacies, hospitals, wholesalers, and government regulators to verify, source, finance, and manage medicines.
Is RxAll a public or private company?
RxAll is a private company. It is classified as venture growth investor backed and is currently operating.
When was RxAll founded?
RxAll was founded in 2019. It employs 11 to 50 people.
Where is RxAll based?
RxAll is headquartered in New Haven, United States, in the North America region.
How does RxAll make money?
Five revenue lines are on record. RxScanner Device Sales are the primary driver. The others are rxDelivered Marketplace Commission, rxPay Financing Services, rx-APIs Licensing and rxPOS Software.
Who are RxAll's main competitors?
Direct peers on record are Sproxil, mPedigree (now RxAfrika), PharmaSecure and RxERP (mPedigree Group). Broad incumbents are Systech (Dover), Optel Group and SAP (Advanced Track and Trace). Emerging players are TruTag Technologies and Zipline. Selcom / Tola Mobile is listed as a regional player.
Does RxAll have an API?
Yes. Rx-APIs provide digitization capabilities for pharmacies through inventory, insurance claims, and invoice financing APIs. The APIs enable pharmacies to automate their operations, connect with financial services, and manage their supply chain digitally.
What industry is RxAll in?
RxAll's product category is Pharmaceutical Authentication Technology. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 3345 and its SIC code is 7372.